Pharmadrug Inc. (TSE:PHRX) has released an update.
PharmaDrug Inc. has announced the strategic appointment of Zalman Goldman, a prominent figure in addiction recovery, to its board of directors, alongside the resignation of former director Nickolai Vassev. Goldman, known for his extensive experience in addiction and recovery programs, brings his expertise to PharmaDrug as they continue to develop controlled substances and natural medicines. The company also granted Goldman 500,000 stock options, signaling confidence in his contributions to PharmaDrug’s future in the pharmaceutical industry.
For further insights into TSE:PHRX stock, check out TipRanks’ Stock Analysis page.
